IGC Pharma, Inc. — Institutional Ownership
Which tracked institutions hold IGC, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
9
Funds holding
$345723
Total value held
Buying
6 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $191433 | 703798 | — | Held |
| 2 | State Street Corp | $54617 | 200799 | — | Held |
| 3 | Northern Trust Corp | $46315 | 170274 | +56867 | +50.14% |
| 4 | Goldman Sachs Group Inc | $17827 | 65541 | — | Held |
| 5 | Truist Financial Corp | $13237 | 48667 | +12000 | +32.73% |
| 6 | Citigroup Inc | $12524 | 46043 | +46043 | NEW BUY |
| 7 | Morgan Stanley | $9574 | 35198 | +80 | +0.23% |
| 8 | Barclays Plc | $196 | 721 | +721 | NEW BUY |
| 9 | Ubs Group Ag | $0 | 1 | +1 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.